Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-02-12 Sale | 2021-02-17 8:39 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K AKDL L.P. Crestline SI (GP) L.P. Crestline Investors Inc. Crestline Management LP 10% Owner | 2,216,798 | $65 | $144,091,870 | 10,084,938 (Indirect) | View |
| 2020-12-11 Sale | 2020-12-15 4:47 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner | 64,624 | $80.14 | $5,179,285 | 12,585,045 (Indirect) | View |
| 2020-08-12 Sale | 2020-08-14 4:50 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K AKDL L.P. Crestline SI (GP) L.P. Crestline Investors Inc. Crestline Management LP 10% Owner | 1,443,247 | $31.65 | $45,678,768 | 12,649,669 (Indirect) | View |
| 2020-06-26 Sale | 2020-06-30 7:17 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner | 250,000 | $23.97 | $5,993,052 | 14,092,916 (Indirect) | View |
| 2020-06-19 Sale | 2020-06-23 5:41 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner | 255,000 | $24.72 | $6,304,373 | 14,342,916 (Indirect) | View |
| 2020-06-05 Sale | 2020-06-09 4:10 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K AKDL L.P. Crestline SI (GP) L.P. Crestline Investors Inc. Crestline Management LP 10% Owner | 1,922,855 | $25.75 | $49,513,516 | 14,597,916 (Indirect) | View |
| 2020-02-26 Sale | 2020-02-28 4:25 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K AKDL L.P. Crestline SI (GP) L.P. Crestline Investors Inc. Crestline Management LP 10% Owner | 3,894,764 | $20.25 | $78,868,971 | 16,520,771 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-02 Gift | 2024-12-04 4:47 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | BRATTON DOUGLAS K 10% Owner | 40,000 | $0 | 10,026,111 (Indirect) | View |
| 2022-06-14 Option Award | 2022-06-16 4:07 pm | N/A N/A | MIDWEST HOLDING INC. | MDWT | BRATTON DOUGLAS K CRESTLINE ASSURANCE HOLDINGS LLC Crestline Management LP Crestline Investors Inc. Director 10% Owner | 2,674 | $0 | 447,845 (Indirect) | View |
| 2021-11-11 Option Award | 2021-11-15 4:18 pm | N/A N/A | MIDWEST HOLDING INC. | MDWT | BRATTON DOUGLAS K CRESTLINE ASSURANCE HOLDINGS LLC Crestline Management LP Crestline Investors Inc. Director 10% Owner | 727 | $0 | 445,171 (Indirect) | View |
| 2021-03-12 Other | 2021-03-16 8:20 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | BRATTON DOUGLAS K MonoLine Partners L.P. MonoLine RX L.P. MonoLine RX II L.P. MonoLine RX III L.P. MonoSol Rx Genpar L.P. MRX Partners LLC Bratton Capital Inc. Bratton Capital Management L.P. 10% Owner | 5,259,492 | $0 | 7,220,655 (Indirect) | View |
| 2021-03-09 Gift | 2021-03-16 8:20 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | BRATTON DOUGLAS K MonoLine Partners L.P. MonoLine RX L.P. MonoLine RX II L.P. MonoLine RX III L.P. MonoSol Rx Genpar L.P. MRX Partners LLC Bratton Capital Inc. Bratton Capital Management L.P. 10% Owner | 62,500 | $0 | 7,220,655 (Direct) | View |
| 2020-12-21 Other | 2020-12-23 6:44 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner | 383,411 | $0 | 12,585,045 (Indirect) | View |
| 2020-07-31 Option Award | 2020-08-04 9:15 pm | N/A 2020-07-31 | MIDWEST HOLDING INC. | MDWT | BRATTON DOUGLAS K CRESTLINE ASSURANCE HOLDINGS LLC Crestline Management LP Crestline Investors Inc. Director 10% Owner | 50,000 | $0 | 50,000 (Indirect) | View |
| 2020-06-16 Option Award | 2020-06-18 4:05 pm | 2021-06-16 2030-06-16 | Aquestive Therapeutics Inc. | AQST | BRATTON DOUGLAS K Director 10% Owner | 14,000 | $0 | 11,592,379 (Direct) | View |
Ownership | 2020-05-04 1:55 pm | N/A N/A | MIDWEST HOLDING INC. | MDWT | BRATTON DOUGLAS K CRESTLINE ASSURANCE HOLDINGS LLC Crestline Management LP Crestline Investors Inc. Director 10% Owner | 0 | $0 | 222,222,222 (Indirect) | View |